PDF herunterladen
CC BY 4.0 · Chinese medicine and natural products 2023; 03(02): e81-e89
DOI: 10.1055/s-0043-1770074
Original Article

Inhibition of Salvianolic Acid B and Ginsenoside Rg1 on Hemorrhagic Transformation after Stroke

Rongrong Xing
1   School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation, Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, Shandong, China
2   Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
,
Yiyu Wang
2   Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
,
Linlin Wang
2   Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
,
Haishang Shen
2   Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
,
Yi Jin
3   Shenzhen Institute for Drug Control, Shenzhen Testing center of medical devices, Shenzhen, China
,
Haoying Yu
2   Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
,
Rongxia Liu
1   School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation, Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, Shandong, China
,
Baohong Jiang
2   Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
› Institutsangaben Funding This study was supported by the Biological Resources Programme, Chinese Academy of Sciences (KFJ-BRP-008-005); Shanghai Science and Technology Development Foundation (21S21901900); the Lingang Laboratory Grant (LG-QS-202206-01); Ministry of Science and Technology of China (2021YFE0111300); National Natural Science Foundation of China (81973513, 81573646).
› Weitere Informationen
Auch verfügbar auf
   Lizenzen und Reprints

Abstract

Objective Application of recanalization on stroke patients is not only limited with time window, but also accompanied with the risk of hemorrhagic transformation. In present study, the effects of salvianolic acid B and ginsenoside Rg1 combination (SalB/Rg1) on time window and hemorrhagic transformation against ischemic stroke was evaluated on middle cerebral artery occlusion (MCAO) mice.

Methods The protection and time window of SalB/Rg1 were estimated through infarct volume, neurobehavioral deficits, and histomorphological examination. The prohibition of SalB/Rg1 against hemorrhagic transformation was detected on MCAO mice stimulated with dextrose and reperfusion. Hemorrhagic transformation was assessed by the Heidelberg Bleeding Classification. The mechanism of SalB/Rg1 against hemorrhagic transformation was identified by immunofluorescence staining and in situ gelatin zymography.

Results First, SalB/Rg1 significantly reduced infarct volume and improved neurobehavior in a dose-dependent manner. Then, the protective time window up to 9 hours was detected for SalB/Rg1 against stroke. Both the dose-dependent efficiency and longtime protection of SalB/Rg1 were further identified based on cytoarchitecture through histopathological stain. Second, SalB/Rg1 downregulated hemorrhagic score, infarct volume, and abnormal neurobehavior. Finally, the inhibition of SalB/Rg1 against hemorrhagic transformation was found to accompany with its protection on the integrity of neurovascular unit. Around the edge area of infarction, SalB/Rg1 attenuated the astrocyte activation, maintained the abundance of junction protein (claudin-5) between endothelial cells, considerably decreased matrix metallopeptidase 9 activity through in situ gelatin zymography.

Conclusion SalB/Rg1 is a promising strategy for further development against stroke, especially against hemorrhagic transformation.

Keywords

stroke - salvianolic acid B - ginsenoside Rg1 - hemorrhagic transformation - neurovascular unit

Animal Ethics Approval

All animal care and experimental procedures were approved by the Institutional Animal Care and Use Committee at Shanghai Institute of Materia Medica (IACUC No.: 2021-04-GDA-77).


CRediT Authorship Contribution Statement

R.X.: Conceptualization, methodology, data curation, and writing original draft. Y.W.: Conceptualization, methodology, resources, data curation, investigation. L.W.: Conceptualization, methodology. H.S., Y.J. and H.Y.: Resources, data curation, investigation, software. B.J. and R.L.: Funding acquisition, supervision, writing review, and editing.


Supplementary Material



Publikationsverlauf

Eingereicht: 01. Dezember 2022

Angenommen: 22. Januar 2023

Artikel online veröffentlicht:
28. Juni 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Abe T, Olanipekun T, Igwe J. et al. Trends, predictors and outcomes of ischemic stroke among patients hospitalized with takotsubo cardiomyopathy. J Stroke Cerebrovasc Dis 2021; 30 (10) 106005
    CrossrefPubMedGoogle Scholar
  • 2 Pahuja M, Chehab O, Ranka S. et al. Incidence and clinical outcomes of stroke in ST-elevation myocardial infarction and cardiogenic shock. Catheter Cardiovasc Interv 2021; 97 (02) 217-225
    CrossrefPubMedGoogle Scholar
  • 3 Kelley RE, Kelley BP. Heart-brain relationship in stroke. Biomedicines 2021; 9 (12) 1835
    CrossrefPubMedGoogle Scholar
  • 4 Nagaraja N, Kubilis PS, Hoh BL, Wilson CA, Khanna AY, Kelly AG. Trends of acute ischemic stroke reperfusion therapies from 2012 to 2016 in the United States. World Neurosurg 2021; 150: e621-e630
    CrossrefPubMedGoogle Scholar
  • 5 Ganesh A, Goyal M. Thrombectomy for acute ischemic stroke: recent insights and future directions. Curr Neurol Neurosci Rep 2018; 18 (09) 59
    CrossrefPubMedGoogle Scholar
  • 6 Shireman TI, Wang K, Saver JL. et al; SWIFT-PRIME Investigators. Cost-effectiveness of solitaire stent retriever thrombectomy for acute ischemic stroke: results from the SWIFT-PRIME trial (solitaire with the intention for thrombectomy as primary endovascular treatment for acute ischemic stroke). Stroke 2017; 48 (02) 379-387
    CrossrefPubMedGoogle Scholar
  • 7 D'Amelio M, Terruso V, Famoso G. et al. Early and late mortality of spontaneous hemorrhagic transformation of ischemic stroke. J Stroke Cerebrovasc Dis 2014; 23 (04) 649-654
    CrossrefPubMedGoogle Scholar
  • 8 Peisker T, Koznar B, Stetkarova I, Widimsky P. Acute stroke therapy: a review. Trends Cardiovasc Med 2017; 27 (01) 59-66
    CrossrefPubMedGoogle Scholar
  • 9 Zhu T, Wang L, Feng Y, Sun G, Sun X. Classical active ingredients and extracts of Chinese herbal medicines: pharmacokinetics, pharmacodynamics, and molecular mechanisms for ischemic stroke. Oxid Med Cell Longev 2021; 2021: 8868941
    PubMedGoogle Scholar
  • 10 Deng Y, Zhang T, Teng F. et al. Ginsenoside Rg1 and Rb1, in combination with salvianolic acid B, play different roles in myocardial infarction in rats. J Chin Med Assoc 2015; 78 (02) 114-120
    CrossrefPubMedGoogle Scholar
  • 11 Li Y, Wang L, Dong Z. et al. Cardioprotection of salvianolic acid B and ginsenoside Rg1 combination on subacute myocardial infarction and the underlying mechanism. Phytomedicine 2019; 57: 255-261
    CrossrefPubMedGoogle Scholar
  • 12 Fu Y, Xing R, Wang L, Yang L, Jiang B. Neurovascular protection of salvianolic acid B and ginsenoside Rg1 combination against acute ischemic stroke in rats. Neuroreport 2021; 32 (13) 1140-1146
    CrossrefPubMedGoogle Scholar
  • 13 Liu Q, Jin Z, Xu Z. et al. Antioxidant effects of ginkgolides and bilobalide against cerebral ischemia injury by activating the Akt/Nrf2 pathway in vitro and in vivo. Cell Stress Chaperones 2019; 24 (02) 441-452
    CrossrefPubMedGoogle Scholar
  • 14 Yaghi S, Willey JZ, Cucchiara B. et al; American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; and Council on Quality of Care and Outcomes Research. Treatment and outcome of hemorrhagic transformation after intravenous alteplase in acute ischemic stroke: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2017; 48 (12) e343-e361
    CrossrefPubMedGoogle Scholar
  • 15 Hadler-Olsen E, Winberg JO. Method for determining gelatinolytic activity in tissue: in situ gelatin zymography. Methods Mol Biol 2019; 1952: 193-199
    CrossrefPubMedGoogle Scholar
  • 16 Jiang B, Chen J, Xu L. et al. Salvianolic acid B functioned as a competitive inhibitor of matrix metalloproteinase-9 and efficiently prevented cardiac remodeling. BMC Pharmacol 2010; 10: 10
    CrossrefPubMedGoogle Scholar
  • 17 Ospel JM, Holodinsky JK, Goyal M. Management of acute ischemic stroke due to large-vessel occlusion: JACC focus seminar. J Am Coll Cardiol 2020; 75 (15) 1832-1843
    CrossrefPubMedGoogle Scholar
  • 18 Ugalde-Triviño L, Díaz-Guerra M. PSD-95: an effective target for stroke therapy using neuroprotective peptides. Int J Mol Sci 2021; 22 (22) 12585
    CrossrefPubMedGoogle Scholar
  • 19 Yeh CY, Schulien AJ, Molyneaux BJ, Aizenman E. Lessons from recent advances in ischemic stroke management and targeting Kv2.1 for neuroprotection. Int J Mol Sci 2020; 21 (17) 6107
    CrossrefPubMedGoogle Scholar
  • 20 Wang T, Duan YM, Fu Q. et al. IM-12 activates the Wnt-β-catenin signaling pathway and attenuates rtPA-induced hemorrhagic transformation in rats after acute ischemic stroke. Biochem Cell Biol 2019; 97 (06) 702-708
    CrossrefPubMedGoogle Scholar
  • 21 Arba F, Piccardi B, Palumbo V. et al. Blood-brain barrier leakage and hemorrhagic transformation: the Reperfusion Injury in Ischemic StroKe (RISK) study. Eur J Neurol 2021; 28 (09) 3147-3154
    CrossrefPubMedGoogle Scholar
  • 22 Candelario-Jalil E, Dijkhuizen RM, Magnus T. Neuroinflammation, stroke, blood-brain barrier dysfunction, and imaging modalities. Stroke 2022; 53 (05) 1473-1486
    CrossrefPubMedGoogle Scholar
  • 23 Liu LR, Liu JC, Bao JS, Bai QQ, Wang GQ. Interaction of microglia and astrocytes in the neurovascular unit. Front Immunol 2020; 11: 1024
    CrossrefPubMedGoogle Scholar
  • 24 Docagne F, Parcq J, Lijnen R, Ali C, Vivien D. Understanding the functions of endogenous and exogenous tissue-type plasminogen activator during stroke. Stroke 2015; 46 (01) 314-320
    CrossrefPubMedGoogle Scholar
  • 25 Jurga AM, Paleczna M, Kadluczka J, Kuter KZ. Beyond the GFAP-astrocyte protein markers in the brain. Biomolecules 2021; 11 (09) 1361
    CrossrefPubMedGoogle Scholar
  • 26 Lv J, Hu W, Yang Z. et al. Focusing on claudin-5: a promising candidate in the regulation of BBB to treat ischemic stroke. Prog Neurobiol 2018; 161: 79-96
    CrossrefPubMedGoogle Scholar
  • 27 Lyden PD. Hemorrhagic transformation during thrombolytic therapy and reperfusion: effects of age, blood pressure, and matrix metalloproteinases. J Stroke Cerebrovasc Dis 2013; 22 (04) 532-538
    CrossrefPubMedGoogle Scholar
  • 28 Mechtouff L, Bochaton T, Paccalet A. et al. Matrix metalloproteinase-9 relationship with infarct growth and hemorrhagic transformation in the era of thrombectomy. Front Neurol 2020; 11: 473
    CrossrefPubMedGoogle Scholar
  • 29 Hu R, Liang J, Ding L. et al. Edaravone dexborneol provides neuroprotective benefits by suppressing NLRP3 inflammasome-induced microglial pyroptosis in experimental ischemic stroke. Int Immunopharmacol 2022; 113 (Pt A): 109315
    CrossrefPubMedGoogle Scholar